Biochemistry/Biology Alum Published

August 7, 2019

Anai Perez '17 was recently published in The Science Daily. In a paper published in the July 31 issue of Science Translational Medicine, researchers at Fred Hutchinson Cancer Research Center used CRISPR-Cas9 to edit long-lived blood stem cells to reverse the clinical symptoms observed with several blood disorders, including sickle cell disease and beta-thalassemia. Read the article.